Kim Witczak is the consumer representative on the FDA’s psychopharmacology committee.  That’s the mostly “professional” group that recommends for or against new drugs to the FDA.   Other than Kim, the regular participants are mostly drug company flacks.  When you read that the FDA’s committee approved a drug 11-1, the one dissenter is probably heroic Kim Witczak.  No one can give you better insight into what goes on in the regulatory agency.  Learn about the latest menace recently unleashed on neurological and psychiatric patients, already causing hundreds of deaths!